EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial

Rasmus Stenlid, Sara Y Cerenius, Hannes Manell, Banu Küçükemre Aydin, Katharina Mörwald, Julian Gomahr, Marina Höghammar Mitkas, Ida Eriksson, Iris Ciba, Sabine Geiersberger, David Thivel, Daniel Weghuber und 2 weitere

Annals of Nutrition and Metabolism · 2023

DOI: 10.1159/000534725 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Nutrition and Metabolism, 2023. Verfasst von Rasmus Stenlid und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden, rasmus.stenlid@mcb.uu.se. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Pediatric Obesity, Martial Arts. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Obesity is associated with chronic inflammation. Chronic inflammation has also been linked to insulin resistance and type 2 diabetes, metabolic associated fatty liver disease, and cardiovascular disease. Glucagon-like peptide-1 (GLP-1) receptor analogs (GLP-1RA) are clinically used to treat obesity, with known anti-inflammatory properties. How the GLP-1RA exenatide effects inflammation in adolescents with obesity is not fully investigated.

Methods

Forty-four patients were randomized to receive weekly subcutaneous injections with either 2 mg exenatide or placebo for 6 months. Plasma samples were collected at baseline and at the end of the study, and 92 inflammatory proteins were measured.

Results

Following treatment with exenatide, 15 out of the 92 proteins were decreased, and one was increased. However, after adjustment for multiple testing, only IL-18Rα was significantly lowered following treatment.

Conclusions

Weekly injections with 2 mg of exenatide lowers circulating IL-18Rα in adolescents with obesity, which may be a potential link between exenatide and its anti-inflammatory effect in vivo. This contributes to exenatide’s pharmaceutical potential as a treatment for obesity beyond weight control and glucose tolerance, and should be further studied mechanistically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Pediatric ObesityMartial ArtsAdolescentHumansExenatideHypoglycemic AgentsPeptidesVenomsInflammationGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

Glucagon-like peptide-1IL-18IL-18RαInflammationObesity

Substanzen

ExenatideHypoglycemic AgentsPeptidesVenomsGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden, rasmus.stenlid@mcb.uu.se.
  • Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden, rasmus.stenlid@mcb.uu.se.
  • Children's Obesity Clinic, Uppsala University Hospital, Uppsala, Sweden, rasmus.stenlid@mcb.uu.se.
  • Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
  • Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
  • Children's Obesity Clinic, Uppsala University Hospital, Uppsala, Sweden.

Zitieren

APA

Stenlid, R., Cerenius, S. Y., Manell, H., Küçükemre Aydin, B., Mörwald, K., Gomahr, J., Höghammar Mitkas, M., Eriksson, I., Ciba, I., Geiersberger, S., Thivel, D., Weghuber, D., Bergsten, P., & Forslund, A. (2023). Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial. Annals of Nutrition and Metabolism. https://doi.org/10.1159/000534725

Vancouver

Stenlid R, Cerenius SY, Manell H, Küçükemre Aydin B, Mörwald K, Gomahr J, et al. Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial. Annals of Nutrition and Metabolism. 2023. doi:10.1159/000534725

BibTeX
@article{Stenlid2023,
  author = {Stenlid, Rasmus and Cerenius, Sara Y and Manell, Hannes and Küçükemre Aydin, Banu and Mörwald, Katharina and Gomahr, Julian and Höghammar Mitkas, Marina and Eriksson, Ida and Ciba, Iris and Geiersberger, Sabine and Thivel, David and Weghuber, Daniel and Bergsten, Peter and Forslund, Anders},
  title = {Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial},
  journal = {Annals of Nutrition and Metabolism},
  year = {2023},
  doi = {10.1159/000534725}
}
Kostenlos starten →